Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Great Western Mining Incoming CEO Edward Loye Targets Undervalued Nevada Assets for Strategic Growth (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Great Western Mining Incoming CEO Edward Loye Targets Undervalued Nevada Assets for Strategic Growth (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unlocking a 9.25% Potential Upside 23 December 2025
Artivion, Inc. (AORT) Stock Analysis: 10% Potential Upside in Medical Device Innovations 23 December 2025
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotechnology Gem with 73% Potential Upside 23 December 2025
Neogen Corporation (NEOG) Stock Analysis: Is a 14.54% Potential Upside Worth Your Investment? 23 December 2025
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Strong Buy Ratings and Nearly 96% Upside Potential 23 December 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Potential 152% Upside Captivates Investors 23 December 2025
Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Unlocking a 27% Potential Upside in Biotech 23 December 2025
Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth Amidst Negative Earnings 23 December 2025
Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 19.26% Potential Upside 23 December 2025
10x Genomics, Inc. (TXG) Investor Outlook: Navigating Growth and Challenges in Health Information Services 23 December 2025
Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 14% Potential Upside in the Biotech Arena 23 December 2025
BioLife Solutions, Inc. (BLFS) Stock Analysis: A 26% Upside Potential in the Healthcare Sector 23 December 2025
Mineralys Therapeutics, Inc. (MLYS): Exploring a 35% Upside Potential in the Biotech Sector 23 December 2025
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 16.08% Upside for Investors 23 December 2025
Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 59% Upside Potential in Biotechnology 23 December 2025
Beam Therapeutics Inc. (BEAM) Stock Analysis: A Biotech Innovator with 64.5% Upside Potential 23 December 2025
GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 11.29% Upside in the Healthcare Diagnostics Sector 23 December 2025
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring an 82% Upside Potential in Biotechnology 23 December 2025
Integra LifeSciences Holdings C (IART) Stock Analysis: Potential 23% Upside Amidst Challenging Metrics 23 December 2025
Great Western Mining Incoming CEO Edward Loye Targets Undervalued Nevada Assets for Strategic Growth (Video) 12 January 2026
Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video) 5 January 2026
Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video) 5 January 2026
NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video) 19 December 2025
RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield 4 December 2025
CMC Markets Presentation: API-Driven Growth Surges as Westpac Deal Ignites Strategic Shift 2 December 2025
Challenger Energy: Uruguay’s AREA OFF-3 Unveils Massive 980 Million Barrel Upside Potential 10 September 2025
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
